People

The Center faculty come from all four UCSF schools and conduct research and teaching in every aspect of tobacco control, from efforts by the tobacco industry to manipulate international politics to the molecular biology of nicotine addiction.

 

Stanton Glantz, PhD

Professor of Medicine
Medicine

RESEARCH INTERESTS: Dr. Glantz, the Truth Initiative Distinguished Professor of Tobacco Control, conducts research on a wide range of topics ranging from the health effects of secondhand smoke (with particular emphasis on the cardiovascular system) to the efficacy of different tobacco control policies. As the tobacco landscape has changed, Dr. Glantz' work has expanded to include e-cigarettes and marijuana, both of which are expanding the tobacco epidemic.

Warren Gold, MD

Professor Emeritus
Medicine

Major academic activities include clinical research programs, training in systems physiology, supervision of the Adult Pulmonary Laboratories, consulting with industry on systems physiology, including the effects of secondhand smoke on lung function. After internal medicine and chief medical residency at the Beth Israel Hospital in Boston (1959-62), he received his research training at the Cardiovascular Research Institute, UCSF with Jay A. Nadel and Julius H.

Jeffrey Gotts, MD, PhD

Assistant Professor
Medicine

Research focuses on the effects of cigarette smoke and e-cigarette aerosols on susceptibility to acute respiratory distress syndrome (ARDS), a major cause of respiratory failure in critically ill patients.

Jennifer Grandis, MD

Professor, Otolaryngology – Head and Neck Surgery
Associate Vice Chancellor, Clinical and Translational Science Institute
Otolaryngology

Jennifer R. Grandis, MD, is a Professor in the Department of Otolaryngology – Head and Neck Surgery (OHNS), and she is the Associate Vice Chancellor—Clinical and Translational Research (AVC-CTR) at the University of California, San Francisco. She received her medical degree from the University of Pittsburgh School of Medicine, Pennsylvania, and she completed her internship from the same institution. Dr. Grandis completed both a residency and an Infectious Disease fellowship from the University of Pittsburgh School of Medicine, Pennsylvania. Prior to joining UCSF, Dr.

Lawrence Green, DrPH, MPH

Professor Emeritus
Epidemiology & Biostatistics

Research on health promotion, including tobacco control, with particular emphasis on knowledge dissemination, transfer, program planning and implementation strategies. His interest is in making practice more evidence-based by making evidence more practice-based. Dr. Green has been the PI on research grants and on predoctoral and postdoctoral training grants from NIH,, the VA , CDC, AHRQ, and the Canadian Institute for Health Research.

Noah Gubner, PhD

Postdoctoral Scholar
Institute for Health Policy Studies

Noah received his PhD in Behavioral Neuroscience at Oregon Health & Science University in Portland, OR. His dissertation research utilized behavioral and genetic animal models that have been well established for alcohol research to study the combined effects of nicotine and alcohol on reward and neuroadaptation, with the goal of understanding why these two drugs share such a high rate of co-abuse.

Joe Guydish, PhD

Professor
Institute for Health Policy Studies

Research on access, delivery, and organization of substance abuse treatment services, treatment effectiveness, and adoption of new treatments into practice settings. He is currently testing an organizational change intervention for treatment programs in tobacco dependence. Joseph Guydish, PhD, MPH, is Professor of Medicine and Health Policy at the University of California, San Francisco.   His research concerns access, delivery, and organization of substance abuse treatment services.

Amy Hafez, PhD

Postdoctoral Scholar
Cardiovascular Research Inst

Sharon Hall, PhD

Professor Emeritus
Psychiatry

Major areas of research are clinical trials for the treatment of nicotine dependence, with emphasis on treatments that reflect a chronic disease model, and on complex populations. Dr. Hall's research is on the treatment of drug abuse, especially tobacco dependence, and better understanding the processes of change through randomized clinical trials and related studies. She is especially interested in the treatment of comorbidities in special populations, and the complexities that comorbidities introduce into treatment.

Arit Harvanko, PhD

Postdoctoral Scholar
Cardiovascular Research Inst

Yogi Hendlin, PhD

Postdoctoral Scholar
Cardiovascular Research Inst

Yogi Hale Hendlin earned his PhD in Environmental Philosophy at the University of Kiel, Germany, after completing doctoral work at UCLA, a Master's at the London School of Economics, and degrees at UC Berkeley. Hendlin's interests are at the intersection of public health policy, social and environmental justice, business ethics, and the philosophy of science.

Carolyn Hendrickson, MD, MPH

Assistant Professor
Medicine

Dr.

Pages